ADVERTISEMENT
Friday, January 27th 2023
Today's Paper
The Kashmir Monitor
🔒 Log in
💲 Contribute
No Result
View All Result
  • LatestLive
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Editorial
  • Business
  • Sports
  • Education
  • Health
  • Tech-Film
  • Auto
  • Crypto
  • Travel
The Kashmir Monitor
  • LatestLive
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Editorial
  • Business
  • Sports
  • Education
  • Health
  • Tech-Film
  • Auto
  • Crypto
  • Travel
The Kashmir Monitor
No Result
View All Result
Home Latest News

CDSCO initiates probe in cough syrup-linked deaths in Uzbekistan

Agencies by Agencies
Dec. 29, 2022 Updated 12:41 pm. IST
A A
CDSCO initiates probe in cough syrup-linked deaths in Uzbekistan


New Delhi, December 29: The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian firm, official sources said on Thursday.

ADVERTISEMENT

The health ministry of Uzbekistan has claimed that the children who died had consumed cough syrup ‘Doc-1 Max’ manufactured by Noida-based Marion Biotech.

AlsoRead

‘Pathaan’: SRK brings ‘HOUSEFULL’ sign back to Kashmir after 32 yrs

5G services launched in Kupwara, 6 other J&K towns

WATCH: Sania Mirza bids tearful adieu to Grand Slams

Hasan Harris, legal representative of Mario Biotech, said the governments of both countries are looking into the matter and inquiring.

“There is no problem from our end and no issue in testing. We have been there for the past 10 years. Once the government report will come, we will look into it. For now the manufacturing has stopped,” Harris said.

According to the ministry, chemical ethylene glycol was found in a batch of syrup during laboratory tests.

ADVERTISEMENT

Sources said the Drugs Controller General of India had sought more information regarding the incident from the Uzbek regulator.

An inspection jointly conducted by the central drugs regulatory team of north zone and state drugs regulatory team was also taken during which samples of the drugs were also lifted.

Earlier this year, death of 70 children in Gambia was linked to cough syrups manufactured by Haryana-based Maiden Pharmaceuticals following which the Haryana-based unit was shut for violation of manufacturing standards.

However, later, the samples tested in a government laboratory in India were found to be complying with specifications.

Tags: cough syrup

Facebook Twitter Youtube Instagram Whatsapp
Logo

© 2023 The Kashmir Monitor - All rights reserved.

No Result
View All Result
  • Home
  • Latest News
  • Lead Stories
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Education
  • Business
  • Environment
  • Health
  • Sports
  • Editors’ Picks
  • Videos
  • Lifestyle
  • Tech-Film
  • Today’s Paper

© 2023 The Kashmir Monitor - All rights reserved.